Market Cap for Insmed (INSM)
According to Insmed's latest reported financial statements, the company's latest reported market cap is $37.18B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INSM
Currently viewingMarket CapSwitch metric
Latest period
$37.18B
YoY change
-22.4%
5Y CAGR
+56.7%
Peak year (2025)
$37.18B
Latest annual
$28.85B
Market Cap history chart for Insmed (INSM) from 2000 to 2026
Market Cap history table for Insmed (INSM) from 2000 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $28.85B | -22.4% | ||
| 2025 | $37.18B | +228.3% | ||
| 2024 | $11.33B | +160.2% | ||
| 2023 | $4.35B | +77.0% | ||
| 2022 | $2.46B | -19.5% | ||
| 2021 | $3.05B | -6.0% | ||
| 2020 | $3.25B | +60.9% | ||
| 2019 | $2.02B | +100.2% | ||
| 2018 | $1.01B | -51.4% | ||
| 2017 | $2.08B | +153.5% | ||
| 2016 | $818.83M | -23.1% | ||
| 2015 | $1.06B | +59.6% | ||
| 2014 | $666.68M | +12.1% | ||
| 2013 | $594.66M | +234.9% | ||
| 2012 | $177.59M | +149.4% | ||
| 2011 | $71.21M | -14.8% | ||
| 2010 | $83.58M | -14.7% | ||
| 2009 | $98.00M | +71.6% | ||
| 2008 | $57.10M | -39.7% | ||
| 2007 | $94.61M | +12.8% | ||
| 2006 | $83.88M | -12.6% | ||
| 2005 | $96.02M | +11.5% | ||
| 2004 | $86.11M | -18.6% | ||
| 2003 | $105.73M | +626.7% | ||
| 2002 | $14.55M | -88.4% | ||
| 2001 | $125.57M | +97.6% | ||
| 2000 | $63.54M | — |
Market Cap values are taken from Insmed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2026 reading of Insmed (INSM) market cap is $28.85B – declined 22.4% year-over-year.
Through 2021–2026 (5 years), Insmed market cap delivered a +56.7% annualised rate; with the latest reading among the more recent periods of the dataset.
Between 2025 and 2026, Insmed market cap declined 22.4%, falling from $37.18B to $28.85B.
2025 marks the peak market cap at $37.18B, with the historical low of $14.55M recorded in 2002.
Within Healthcare, Insmed (INSM) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
Insmed Market Cap by Year
Insmed Market Cap 2026: $28.85B
Insmed market cap in 2026 was $28.85B, declined 22.4% below 2025.
Insmed Market Cap 2025: $37.18B
Insmed market cap in 2025 was $37.18B, surged 228.3% from 2024. This figure represents the highest annual value in the available history.
Insmed Market Cap 2024: $11.33B
Insmed market cap in 2024 was $11.33B, surged 160.2% from 2023.
Insmed Market Cap 2023: $4.35B
Insmed market cap in 2023 was $4.35B, surged 77.0% from 2022.
Insmed Market Cap 2022: $2.46B
Insmed market cap in 2022 was $2.46B.
See more financial history for Insmed (INSM).
Sector peers — Market Cap
Companies in the same sector as Insmed, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Insmed's market cap?
- Latest reported market cap for Insmed (INSM) is $37.18B (period ending December 31, 2025).
How has Insmed market cap changed year-over-year?
- Insmed (INSM) market cap changed -22.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Insmed market cap?
- Insmed (INSM) market cap compound annual growth rate is +56.7% over the most recent 5 years available.
When did Insmed market cap hit its highest annual value?
- Insmed market cap reached its highest annual value of $37.18B in 2025.
What was Insmed market cap in 2025?
- Insmed (INSM) market cap in 2025 was $37.18B.
What was Insmed market cap in 2026?
- Insmed (INSM) market cap in 2026 was $28.85B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INSM Overview
Company profile, financial tools, and key metrics
INSM Revenue Counter
Earns $19.23 every second. See per minute, hour, and day.
INSM Earnings Counter
Loses −$40.49 per second. See per minute, hour, and day.
INSM Economic Scale
Exceeds Micronesia, Fed. Sts.'s GDP. Compare with world economies.
INSM What If Invested
What if you had invested $1,000? See historical returns from any date.
INSM How It Makes Money
Discover visual breakdown of $606.42M in revenue — where it comes from and where it goes.
INSM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INSM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INSM Daily Price Character
Explosive · 46.7% historical win rate (green days). Streaks & record days.
INSM Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.
INSM Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.